- Home
- NBTX vs CLBR Comparison
NBTX vs CLBR Comparison
Compare NBTX & CLBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- CLBR
- Stock Information
- Founded
- NBTX 2003
- CLBR 2023
- Country
- NBTX France
- CLBR United States
- Employees
- NBTX N/A
- CLBR N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- CLBR
- Sector
- NBTX Health Care
- CLBR
- Exchange
- NBTX Nasdaq
- CLBR Nasdaq
- Market Cap
- NBTX 201.9M
- CLBR 219.3M
- IPO Year
- NBTX 2020
- CLBR 2023
- Fundamental
- Price
- NBTX $4.00
- CLBR $10.44
- Analyst Decision
- NBTX Strong Buy
- CLBR
- Analyst Count
- NBTX 2
- CLBR 0
- Target Price
- NBTX $11.50
- CLBR N/A
- AVG Volume (30 Days)
- NBTX 6.4K
- CLBR 72.1K
- Earning Date
- NBTX 11-19-2024
- CLBR 01-01-0001
- Dividend Yield
- NBTX N/A
- CLBR N/A
- EPS Growth
- NBTX N/A
- CLBR N/A
- EPS
- NBTX N/A
- CLBR N/A
- Revenue
- NBTX $45,220,186.00
- CLBR N/A
- Revenue This Year
- NBTX N/A
- CLBR N/A
- Revenue Next Year
- NBTX N/A
- CLBR N/A
- P/E Ratio
- NBTX N/A
- CLBR $132.14
- Revenue Growth
- NBTX 526.17
- CLBR N/A
- 52 Week Low
- NBTX $4.04
- CLBR $9.16
- 52 Week High
- NBTX $8.96
- CLBR $10.48
- Technical
- Relative Strength Index (RSI)
- NBTX 37.42
- CLBR 74.47
- Support Level
- NBTX $4.07
- CLBR $10.31
- Resistance Level
- NBTX $4.44
- CLBR $10.35
- Average True Range (ATR)
- NBTX 0.21
- CLBR 0.02
- MACD
- NBTX -0.03
- CLBR 0.01
- Stochastic Oscillator
- NBTX 0.00
- CLBR 93.75
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About CLBR Colombier Acquisition Corp. II
Colombier Acquisition Corp II is a blank check company.